2023 Annual Meeting | H66 - Leveraging Inclusion to Mitigate Bias in Challenging Times (Leadership University)
| 12:00 PM - 12:05 PM EST | Introduction |
Introduction
Jeffrey C. McClean II, MD, FAAN |
| 12:05 PM - 12:50 PM EST | Speaker |
Keynote Presentation
Laraine Kaminsky |
| 12:50 PM - 01:20 PM EST | Speaker |
Panel Discussion
Jeffrey C. McClean II, MD, FAAN, Charles C. Flippen II, MD, FAAN, Salvador Cruz-Flores, MD, FAAN, Laraine Kaminsky, Erika T. Marulanda, MD, FAAN |
| 01:20 PM - 01:30 PM EST | Q&A |
Questions and Answers
|
| Charles C. Flippen II, MD, FAAN | Dr. Flippen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Carelon. Dr. Flippen has a non-compensated relationship as a committee member with American Headache Society that is relevant to AAN interests or activities. Dr. Flippen has a non-compensated relationship as a committee/task force member with American Neurological Association that is relevant to AAN interests or activities. |
| Erika T. Marulanda, MD, FAAN | Dr. Marulanda has nothing to disclose. |
| Salvador Cruz-Flores, MD, FAAN | The institution of Dr. Cruz-Flores has received research support from University of Texas System. |
| Laraine Kaminsky | Laraine Kaminsky has nothing to disclose. |
| Jeffrey C. McClean II, MD, FAAN | Dr. McClean has or had stock in Tesla.Dr. McClean has or had stock in Netflix. An immediate family member of Dr. McClean has or had stock in Nike.Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with 好色先生. |